1 |
Orsucci D, Ienco EC, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: A review. Drugs Context 2020;9:2020-5-1.
|
2 |
Verstrepen K, Baisier L, De Cauwer H. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg 2020;120(5):1051-60.
DOI
|
3 |
Aoyagi Y, Ohashi M, Funahashi R, Otaka Y, Saitoh E. Oropharyngeal dysphagia and aspiration pneumonia following coronavirus disease 2019: A case report. Dysphagia 2020;35(4):545-8.
DOI
|
4 |
Helding L, Carroll TL, Nix J, Johns MM, LeBorgne WD, Meyer D. COVID-19 after effects: Concerns for singers. J Voice 2022;36(4):586.e7-14.
|
5 |
Altman KW, Noordzij JP, Rosen CA, Cohen S, Sulica L. Neurogenic cough. Laryngoscope 2015;125(7):1675-81.
DOI
|
6 |
Qi R, Chen W, Liu S, Thompson PM, Zhang LJ, Xia F, et al. Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: Prevalence and associated biopsychosocial risk factors. medRxiv [Preprint]. 2020 [cited 2022 October 20]. Available from: https://doi.org/10.1101/2020.05.08.20031666.
DOI
|
7 |
Tepe ES, Deutsch ES, Sampson Q, Lawless S, Reilly JS, Sataloff RT. A pilot survey of vocal health in young singers. J Voice 2002;16(2):244-50.
DOI
|
8 |
Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome. Information for healthcare providers [Internet]. Atlanta, GA: Centers for Disease Control and Prevention [cited 2022 October 20]. Available from: https://www.cdc.gov/me-cfs/healthcare-providers/index.html.
|
9 |
World Health Organization. WHO virtual press conference on COVID-19 [Internet]. Geneva: World Health Organization [cited 2022 October 22]. Available from: https://www.who.int/.
|
10 |
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARSCoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564-7.
DOI
|
11 |
World Health Organization. Modes of transmission of the COVID-19 virus [Internet]. Geneva: World Health Organization [cited 2022 October 22]. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations.
|
12 |
Cheng X, Liu J, Li N, Nisenbaum E, Sun Q, Chen B, et al. Otolaryngology providers must be alert for patients with mild and asymptomatic COVID-19. Otolaryngol Head Neck Surg 2020;162(6):809-10.
DOI
|
13 |
Asadi S, Bouvier N, Wexler AS, Ristenpart WD. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol Sci Technol 2020;54(6):635-8.
DOI
|
14 |
Piazza C, Filauro M, Dikkers FG, Nouraei SAR, Sandu K, Sittel C, et al. Long-term intubation and high rate of tracheostomy in COVID-19 patients might determine an unprecedented increase of airway stenoses: A call to action from the European Laryngological Society. Eur Arch Otorhinolaryngol 2021;278(1):1-7.
DOI
|
15 |
Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience. Anesthesiology 2020;132(6):1317-32.
DOI
|
16 |
Colice GL, Stukel TA, Dain B. Laryngeal complications of prolonged intubation. Chest 1989;96(4):877-84.
DOI
|
17 |
Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J Aerosol Sci 1986;17(5):811-25.
DOI
|
18 |
Jackson JC, Ely EW, Morey MC, Anderson VM, Denne LB, Clune J, et al. Cognitive and physical rehabilitation of intensive care unit survivors: Results of the RETURN randomized controlled pilot investigation. Crit Care Med 2012;40(4):1088-97.
DOI
|
19 |
Murray A, Gerada C, Morris J. We need a nightingale model for rehab after covid-19 [Internet]. London: Health Service Journal [cited 2022 October 20]. Available from: https://www.hsj.co.uk/commissioning/we-need-a-nightingale-model-for-rehab-after-covid-19-/7027335.article.
|
20 |
Carfi A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324(6):603-5.
DOI
|
21 |
Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: A longitudinal study. Radiology 2020;296(2):E55-64.
DOI
|
22 |
Archer SK, Iezzi CM, Gilpin L. Swallowing and voice outcomes in patients hospitalized with COVID-19: An observational cohort study. Arch Phys Med Rehabil 2021;102(6):1084-90.
DOI
|
23 |
Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020;26(8):1200-4.
DOI
|
24 |
George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir Med 2020;8(8):807-15.
DOI
|
25 |
Naunheim MR, Zhou AS, Puka E, Franco RA Jr, Carroll TL, Teng SE, et al. Laryngeal complications of COVID-19. Laryngoscope Investig Otolaryngol 2020;5(6):1117-24.
DOI
|
26 |
Regan J, Walshe M, Lavan S, Horan E, Gillivan Murphy P, Healy A, et al. Post-extubation dysphagia and dysphonia amongst adults with COVID-19 in the Republic of Ireland: A prospective multi-site observational cohort study. Clin Otolaryngol 2021;46(6):1290-9.
DOI
|
27 |
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052-9.
DOI
|